GLP-1 medications cut colon cancer death rates in half

today.ucsd.edu

GLP-1 medications significantly reduced death rates in colon cancer patients. A study of over 6,800 patients found those on GLP-1 drugs were less than half as likely to die within five years, even after accounting for other health factors. Researchers suggest potential direct anti-cancer effects or indirect benefits from improved metabolic health, with further trials needed.


With a significance score of 6.3, this news ranks in the top 0.1% of today's 33448 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: